MedTrace Logo

Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer

NCT03319069 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-10-24

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy and toxicities of hypofractionated radiotherapy with conventional fractionated radiotherapy in high risk breast cancer patients treated with mastectomy. It's hypothesized that the efficacy and toxicities are similar between the two groups.

Conditions

Interventions

RADIATION

Hypofractionated radiotherapy

Hypofractionated radiotherapy 43,5 GY/15 fractions (f)/3ws. to chest wall and supraclavicular nodal region. .

RADIATION

Conventional fractionated radiotherapy

50 Gray(GY)/ 25f/5 weeks(5w) to chest wall and supraclavicular nodal region

Sponsors & Collaborators

  • Ahmed Ahm

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2018-09-01
Completion
2019-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03319069 on ClinicalTrials.gov